BiotechTube

Dextroamphetamine + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Methamphetamine Addiction

Conditions

Methamphetamine Addiction

Trial Timeline

Sep 1, 2006 → Aug 1, 2011

NCT ID
NCT00630682

About Dextroamphetamine + Placebo

Dextroamphetamine + Placebo is a phase 2 stage product being developed by Pacific Biosciences for Methamphetamine Addiction. The current trial status is completed. This product is registered under clinical trial identifier NCT00630682. Target conditions include Methamphetamine Addiction.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00630682Phase 2Completed

Competing Products

6 competing products in Methamphetamine Addiction

See all competitors
ProductCompanyStageHype Score
CPP-109 vigabatrin + Matching PlaceboCatalyst PharmaceuticalsPhase 2
47
A single oral 5 mg of duterium labeled methamphetaminePacific BiosciencesApproved
77
modafinilPacific BiosciencesPhase 2
44
NaltrexonePacific BiosciencesPhase 2
44
ModafinilPacific BiosciencesPhase 2
44
Ibudilast 20mg + Ibudilast 50mg + Placebo oral tabletMediciNovaPhase 1
25

Other Products from Pacific Biosciences

pantoprazole + bismuth + metronidazole + tetracyclineApproved
77
EmtricitabineApproved
77
A single oral 5 mg of duterium labeled methamphetamineApproved
77
RamiprilApproved
77
Emtricitabine plus adefovir dipivoxilApproved
77